Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation
- PMID: 16563963
- DOI: 10.1016/j.healun.2005.11.436
Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation
Abstract
Background: A scoring system was recently proposed to grade the severity of primary graft dysfunction (PGD), a frequent early complication of lung transplantation. The purposes of this study are to: (1) validate the PGD grading system with respect to patient outcomes; and (2) compare the performance of criteria employing the arterial oxygenation to fraction of inspired oxygen (P/F) ratio to an alternative grading system employing the oxygenation index (OI).
Methods: We retrospectively reviewed the medical records of 402 patients having undergone lung transplantation at our institution from 1992 through 2004. The ISHLT PGD grading system was modified and grades were assigned up to 48 hours post-transplantation as follows: Grade 1 PGD, P/F > 300; Grade 2, P/F 200 to 300; and Grade 3, P/F < 200. A worst score T(0-48) was also assigned, which reflects the highest grade recorded between T0 and T48.
Results: The prevalence of severe PGD (P/F Grade 3) declined after transplant, from 25% at T0 to 15% at T48. Grouping patients by P/F grade at T48 demonstrated the clearest differentiation of 90-day death rates (Grade 1, 7%; Grade 2, 12%; Grade 3, 33%) (p = 0.0001). T48 OI grade also differentiates 90-day death rates. There was no difference in longer-term survival between patients with PGD Grades 1 and 2. OI grade at T0 qualitatively improved differential mortality between Grades 1 and 2; however, the differences did not reach statistical significance. Patients with a worst score T(0-48) of Grade 3 PGD did have significantly decreased long-term survival, as well as longer ICU and hospital stay, when compared with Grades 1 and 2 PGD. Significant risk factors for short- and long-term mortality in our multivariate model were P/F Grade 3 [worst score T(0-48) as well as T0 grade], single-lung transplant, use of cardiopulmonary bypass and high pre-operative mean pulmonary artery pressure.
Conclusions: There is an increased risk of short- and long-term mortality and length of hospital stay associated with severe (Grade 3) PGD. The proposed ISHLT grading system can rapidly identify patients with poor outcomes who may benefit from early, aggressive treatment. Refinement of the scoring system may further improve patient risk stratification.
Similar articles
-
Does Perfadex affect outcomes in clinical lung transplantation?J Heart Lung Transplant. 2005 Dec;24(12):2243-8. doi: 10.1016/j.healun.2005.06.019. J Heart Lung Transplant. 2005. PMID: 16364877
-
Risk factors for primary graft dysfunction after lung transplantation.J Thorac Cardiovasc Surg. 2006 Jan;131(1):73-80. doi: 10.1016/j.jtcvs.2005.08.039. Epub 2005 Dec 5. J Thorac Cardiovasc Surg. 2006. PMID: 16399297
-
Primary graft dysfunction and long-term pulmonary function after lung transplantation.J Heart Lung Transplant. 2007 Oct;26(10):1004-11. doi: 10.1016/j.healun.2007.07.018. J Heart Lung Transplant. 2007. PMID: 17919620
-
Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system.J Heart Lung Transplant. 2007 May;26(5):431-6. doi: 10.1016/j.healun.2007.01.029. Epub 2007 Mar 21. J Heart Lung Transplant. 2007. PMID: 17449410 Review.
-
Impact of secondary pulmonary hypertension on lung transplant outcome.J Heart Lung Transplant. 2005 Sep;24(9):1254-9. doi: 10.1016/j.healun.2004.08.009. J Heart Lung Transplant. 2005. PMID: 16143242 Review.
Cited by
-
Influence of donor-recipient gender mismatch on graft function and survival following lung transplantation.Interact Cardiovasc Thorac Surg. 2013 Apr;16(4):426-35. doi: 10.1093/icvts/ivs570. Epub 2013 Jan 15. Interact Cardiovasc Thorac Surg. 2013. PMID: 23322094 Free PMC article.
-
Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury.J Heart Lung Transplant. 2015 Feb;34(2):247-53. doi: 10.1016/j.healun.2014.09.034. Epub 2014 Oct 2. J Heart Lung Transplant. 2015. PMID: 25455749 Free PMC article.
-
The role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients.Am J Med Sci. 2015 Feb;349(2):117-23. doi: 10.1097/MAJ.0000000000000361. Am J Med Sci. 2015. PMID: 25310510 Free PMC article. Clinical Trial.
-
Primary Graft Dysfunction after Lung Transplantation.Turk J Anaesthesiol Reanim. 2015 Dec;43(6):418-23. doi: 10.5152/TJAR.2015.16443. Epub 2015 Dec 1. Turk J Anaesthesiol Reanim. 2015. PMID: 27366539 Free PMC article. Review.
-
Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.Curr Opin Organ Transplant. 2015 Oct;20(5):506-14. doi: 10.1097/MOT.0000000000000232. Curr Opin Organ Transplant. 2015. PMID: 26262465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous